02.12.2012 Views

New Doctor - Medical Protection Society

New Doctor - Medical Protection Society

New Doctor - Medical Protection Society

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

8<br />

MEDICOETHICAL FEATURE<br />

NEW DOCTOR | VOLUME 5 | ISSUE 2 | 2012 | UNITED KINGDOM www.mps.org.uk<br />

apply to anyone aged 18 or over<br />

who suffers from a mental disorder<br />

or disability of the mind, and who<br />

lacks the capacity to give informed<br />

consent to the arrangements made<br />

for their care and/or treatment. The<br />

safeguards are designed to:<br />

■ ■ Ensure people can be given<br />

the care they need in the least<br />

restrictive regimes<br />

■ ■ Prevent arbitrary decisions that<br />

deprive vulnerable people of their<br />

liberty.<br />

Elderly patients<br />

It shouldn’t be assumed that people are<br />

not able to make their own decisions,<br />

simply because of their age or frailty. 4<br />

As patients get older, there is a<br />

temptation to believe that they have<br />

decreased capacity to take decisions<br />

about their treatment. However,<br />

you should always work on the<br />

assumption that capacity to give<br />

consent for treatment exists, unless<br />

it is proven otherwise.<br />

End of life decisions<br />

Before people lose the capacity to<br />

consent to treatment, particularly as<br />

a result of a progressive condition,<br />

they may make an advance decision<br />

(AD) or directive (or living will). If the<br />

statement was made by a competent<br />

adult, and there is no reason to<br />

believe that they have changed their<br />

mind, it should be respected.<br />

The MCA provides some protection<br />

for doctors dealing with advance<br />

decisions. In particular, it provides<br />

a safeguard for doctors acting on<br />

advance decisions. You will not be<br />

held liable if you:<br />

■ ■Are<br />

in doubt over whether there is<br />

an AD and provide treatment<br />

■ ■ Believe a valid and applicable AD<br />

exists and withhold or withdraw<br />

treatment.<br />

Where there is doubt, the courts will<br />

decide whether an AD exists and<br />

whether it is valid and applicable to<br />

treatment. Until the court decides,<br />

nothing should prevent the provision<br />

of life-sustaining treatment, or<br />

anything believed to be necessary to<br />

prevent a serious deterioration in the<br />

patient’s condition. ADs (or directives)<br />

are governed by common law rather<br />

than by legislation in Scotland and<br />

Northern Ireland.<br />

REFERENCES<br />

Children and young people<br />

In England and Wales, anyone aged<br />

18 and over is assumed to be a<br />

competent adult and can give their<br />

consent. In Scotland, the legal age<br />

of capacity is 16. Young people aged<br />

16-17 are usually treated as if they<br />

are adults in that they are usually<br />

assumed to be competent. However,<br />

if they refuse a treatment, this can be<br />

overridden either by someone with<br />

parental responsibility or the courts.<br />

In patients under the age of 16, it<br />

is for the doctor to decide whether a<br />

child has reached a suitable level of<br />

maturity and understanding. Children<br />

under 16 are often competent and in<br />

the case of Gillick v West Norfolk and<br />

Wisbech Area Health Authority (1985)<br />

it was found that a parent’s right to<br />

consent to treatment on behalf of a<br />

child ends when the child has sufficient<br />

intelligence and understanding to<br />

consent to the treatment themselves,<br />

ie, when the child is “Gillick competent”.<br />

If children under 16 refuse a<br />

treatment, this can be overridden by<br />

someone with parental responsibility<br />

or the courts. However, when there<br />

is a difference of opinion between the<br />

young person and their parents, this<br />

is usually resolved within the family.<br />

If there is no need for an immediate<br />

decision, it is clearly preferable to delay<br />

a decision until this can be resolved.<br />

The treatment of young children<br />

can be a contentious issue and it is<br />

important to seek guidance from your<br />

senior or MPS.<br />

Parental responsibility<br />

For young children who are not<br />

competent to give their consent,<br />

someone with parental responsibility<br />

can give consent on their behalf. The<br />

mother automatically has parental<br />

responsibility unless she lacks capacity<br />

herself. A father will have responsibility if:<br />

■ ■ He is married to the mother of his<br />

child (or was at the time of birth)<br />

■ ■ He has made a parental responsibility<br />

agreement with the mother<br />

■ ■ He has obtained a court order<br />

granting him parental responsibility<br />

■ ■The<br />

child was born after 15<br />

April 2002 in Northern Ireland, 1<br />

December 2003 in England or<br />

Wales, or 4 May 2006 in Scotland<br />

and the father is named on the<br />

child’s birth certificate.<br />

1. Chester v Afshar, UKHL 41 Pt 2 (2004)<br />

2. GMC, Consent: Patients and <strong>Doctor</strong>s Making Decisions Together (2008)<br />

– www.gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp<br />

3. MCA, Code of Practice (2005) – www.justice.gov.uk/protecting-the-vulnerable/mental-capacity-act<br />

4. DH, Seeking Consent: Working with Older People (2001) – www.dh.gov.uk/en/index.htm<br />

5. Ibid 2.<br />

WHAT PATIENTS SHOULD BE TOLD<br />

■ ■ All details of the diagnosis, and<br />

prognosis, and the likely prognosis if<br />

the condition is left untreated<br />

■ ■ Any uncertainties about the diagnosis,<br />

including options for further<br />

investigation prior to treatment<br />

■ ■ All options for treatment or<br />

management of their condition,<br />

including the option not to treat<br />

■ ■ The purpose of a proposed<br />

investigation or treatment; details of<br />

the procedures or therapies involved<br />

■ ■ Explanations of the likely benefits and<br />

the probabilities of success for each<br />

option; and discussion of any serious<br />

or frequently occurring risks<br />

■ ■ Advice about whether a proposed<br />

treatment is experimental<br />

■ ■ How and when the patient’s<br />

condition, and any side effects, will be<br />

monitored or reassessed<br />

■ ■ A reminder that they can change their<br />

minds about a decision at any time.<br />

■ ■ A reminder that they have a right to<br />

seek a second opinion.<br />

USEFUL LINKS<br />

MPS has produced factsheets and<br />

booklets on the following topics. Visit:<br />

www.medicalprotection.org/uk/<br />

factsheets<br />

LOOKING FOR EVIDENCE FOR<br />

YOUR ePORTFOLIO?<br />

MPS is committed to education and<br />

training. As well as helping you provide<br />

the best care for your patients, we want<br />

to support your development. That is<br />

why we have developed two online<br />

learning modules on the topic covered<br />

in this article, so that you can download<br />

a certificate of completion as evidence<br />

of your learning for your ePortfolio.<br />

What to do next….<br />

■ ■ Once you’ve read this article, simply<br />

go to www.mps.org.uk/e-portfolio<br />

where you can register for the<br />

E-learning platform<br />

■ ■ You’ll need your membership details<br />

to register and log on<br />

■ ■ Once logged on, you will be able<br />

to access the consent modules<br />

highlighted on the home page<br />

■ ■ You can complete the modules at a<br />

time that suits you<br />

■ ■ Download your certificate of<br />

completion and any supporting notes<br />

■ ■ Other modules on a wide range<br />

of subjects can also be accessed<br />

through the E-learning platform

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!